Table: begin end state 1 5 non-cytoplasmic 6 25 transmembrane 26 31 cytoplasmic 32 52 transmembrane 53 63 non-cytoplasmic 64 83 transmembrane 84 103 cytoplasmic 104 133 transmembrane 134 138 non-cytoplasmic 139 161 transmembrane 162 180 cytoplasmic 181 201 transmembrane 202 230 non-cytoplasmic 231 254 transmembrane 255 264 cytoplasmic 265 287 transmembrane 288 307 non-cytoplasmic 308 322 transmembrane 323 341 non-cytoplasmic 342 384 transmembrane 385 388 non-cytoplasmic 389 412 transmembrane 413 423 cytoplasmic 424 448 transmembrane 449 449 non-cytoplasmic
Input: >AO353_05900 FitnessBrowser__pseudo3_N2E3:AO353_05900 MAPSFGYWLLVYAAIAIIALIVLIARYRLNPFIVITLVSIGLALLAGMPPSGVVGAYEAG VGKTLGHIALVVALGTMLGKMMAESGGAEQMARTLIERFGEKNAHWAMVCIAFLVGLPLF FEVGFVLLVPIAFTVARRVGVSILMVGLPMVAGLSVVHALVPPHPAAMLAVQAYQASVGQ TLLYAILIGIPTAIIAGPLYAKFIVPRIQLPAENPLERQFIEREPRDRLPGFGITMATIL LPVVLMLIGGWANLISTPGSGFNQFLLFIGNSVIALLLATLLSFWTLGLAQGFNRESILK FTNECLAPTASITLLVGAGGGLNRILVDAGVTDQIVGLAHEFHLSPLLMGWLFAALMRIA TGSATVAMTTASGVVAPVAIGLGYPHPELLVLATGAGSVIFSHVNDGGFWLVKEYFNMTV TQTFKTWTVLETLISLVAFGLTLGLSYVL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server